Genetics/Enhancement State of the Art and Science Jan 2021 “Prevention” and Human Gene Editing Governance Eric T. Juengst, PhD The Holocaust and the racial hygiene doctrine that helped rationalize it still overshadow contemporary debates about using gene editing for disease prevention. AMA J Ethics. 2021;23(1):E49-54. doi: 10.1001/amajethics.2021.49. Medicine and Society Dec 2019 An Exclusive Interview With CRISPR Sean C. McConnell, PhD Clinically and ethically relevant questions are related to patient safety, therapeutic efficacy, equitable access, and global governance over humanity’s genetic legacy. AMA J Ethics. 2019;21(12):E1079-1088. doi: 10.1001/amajethics.2019.1079. AMA Code Says Dec 2019 AMA Policies and Code of Medical Ethics’ Opinions Related to Human Genome Editing Abigail Scheper Gene editing reminds professionals and the public that this technology’s reach goes beyond treating somatic disease to germline consequences yet unknown. AMA J Ethics. 2019;21(12):E1056-1058. doi: 10.1001/amajethics.2019.1056. Podcast Dec 2019 Ethics Talk: How Do We Prepare for Human Gene Editing? Dr Sean C. McConnell provides an introduction to gene editing, and Scott J. Schweikart discusses what prudent governance requires. State of the Art and Science Dec 2017 Is Editing the Genome for Climate Change Adaptation Ethically Justifiable? Lisa Soleymani Lehmann, MD, PhD, MSc AMA J Ethics. 2017;19(12):1186-1192. doi: 10.1001/journalofethics.2017.19.12.stas1-1712. Podcast Dec 2016 Ethics Talk: The Limits and Possibilities of Biomedical Enhancement - An Interview with Dr. Allen Buchanan State of the Art and Science Dec 2000 Is Genetic Enhancement a Gift to Future Generations? Faith Lagay, PhD Virtual Mentor. 2000;2(12):136-138. doi: 10.1001/virtualmentor.2000.2.12.gnth1-0012.